Health Care

VSee Health’s zero‑price share‑swap for VSee Lab reveals a long‑term strategy: debt relief, integrated telehealth‑lab synergy, and insider confidence amid steep share declines.

Merck insider buying signals confidence in its growing molnupiravir and mRNA oncology pipeline, boosting investor optimism for a potential rally.

Waldman Reid Alexander’s 47,250‑option exercise signals board confidence as Achieve Life Sciences prepares a $50 M capital raise to fuel clinical milestones and growth.

Insider buying at Fennec Pharma signals confidence in its platinum‑ototoxicity pipeline; a cautious yet optimistic signal for investors weighing risk‑reward.

Insightful analysis of CFO Laponis Adam’s recent Twist Bioscience share sales: pattern, price trends, and what it means for investor confidence.

CEO Warmuth Markus sells 5,466 shares of Monte Rosa Therapeutics at $19–$20, showing disciplined, long‑term trading without hinting at a sell‑off.

Vertex insider sales continue as EVP & CMO Carmen Bo Cic sells 1,974 shares at $450, amid FDA approval of povetacicept and market volatility.

Agilent insider trading insights reveal confidence amid growth—explore how exec moves, AI, and value‑based reimbursement drive life‑sciences innovation.

Merck insider buying signals confidence in its antiviral and oncology pipeline—an encouraging cue for investors amid evolving value‑based healthcare dynamics.

Explore MCKESSON CORP’s insider sales: LeAnn B. Smith’s 1,810‑share June 1 drop, trading patterns, and what it signals for investors.